Evaluation of DNA Methylation of MAP9 Gene in Breast Cancer as Epigenetic Biomarker
نویسندگان
چکیده
منابع مشابه
the study of aaag repeat polymorphism in promoter of errg gene and its association with the risk of breast cancer in isfahan region
چکیده: سرطان پستان دومین عامل مرگ مرتبط با سرطان در خانم ها است. از آنجا که سرطان پستان یک تومور وابسته به هورمون است، می تواند توسط وضعیت هورمون های استروئیدی شامل استروژن و پروژسترون تنظیم شود. استروژن نقش مهمی در توسعه و پیشرفت سرطان پستان ایفا می کند و تاثیر خود را روی بیان ژن های هدف از طریق گیرنده های استروژن اعمال می کند. اما گروه دیگری از گیرنده های هسته ای به نام گیرنده های مرتبط به ا...
15 صفحه اولDNA methylation as an epigenetic biomarker in colorectal cancer
Sporadic colorectal cancer (CRC) is a consequence of the accumulation of genetic and epigenetic alterations that result in the transformation of normal colonic epithelial cells to adenocarcinomas. Studies have indicated that a common event in the tumorigenesis of CRC is the association of global hypomethylation with discrete hypermethylation at the promoter regions of specific genes that are in...
متن کاملDNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker
Using whole blood from 15 twin pairs discordant for breast cancer and high-resolution (450K) DNA methylation analysis, we identified 403 differentially methylated CpG sites including known and novel potential breast cancer genes. Confirming the results in an independent validation cohort of 21 twin pairs determined the docking protein DOK7 as a candidate for blood-based cancer diagnosis. DNA h...
متن کاملDNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of Cancer
In light of the high incidence and mortality rates of cancer, early and accurate diagnosis is an important priority for assigning optimal treatment for each individual with suspected illness. Biomarkers are crucial in the screening of patients with a high risk of developing cancer, diagnosing patients with suspicious tumours at the earliest possible stage, establishing an accurate prognosis, an...
متن کاملevaluation of methylation status in the 5'utr promoter region of the dbc2 gene as a biomarker in sporadic breast cancer
objective: breast cancer is one of the most common malignancies in women worldwide. it is caused by a number of genetic and epigenetic factors. aberrant hypermethylation of the promoter regions in specific genes is a key event in the formation and progression of breast cancers as well as the dbc2 gene, as a tumor suppressor gene. different studies show that the dbc2 gene is inactivated through ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Molecular Biomarkers & Diagnosis
سال: 2016
ISSN: 2155-9929
DOI: 10.4172/2155-9929.s8-015